Key takeaways
Vyvanse is a prescription drug that’s FDA-approved to treat ADHD in people 6 years and older and binge eating disorder in adults.
Some Blue Cross Blue Shield (BCBS) plans cover brand-name Vyvanse, while others cover only generic lisdexamfetamine or require prior authorization for the brand-name version.
Certain BCBS plans may require prior authorization before issuing coverage, which may involve additional documentation or trying other drugs first.
Some BCBS plans cover brand-name Vyvanse (lisdexamfetamine), but it usually comes with higher out-of-pocket costs. In many cases, insurance plans require prior authorization (approval) from your doctor or healthcare provider before they agree to pay for it. The generic version is usually the preferred option on formularies (covered drug lists) and is more likely to be covered. Coverage also depends on whether the prescription is for an FDA-approved use and whether your plan requires you to try other medications first.
Save up to 80% on Vyvanse with SingleCare
Different pharmacies offer different prices for the same medication. SingleCare helps find the best price for you.
Does Blue Cross Blue Shield cover Vyvanse?
Sometimes. The Blue Cross and Blue Shield Association is actually a collection of independent licensees that handle insurance for their individual states, which means they often have different plans. There are many variables at play when it comes to prescription drug coverage, including the type of insurance (e.g., private, Medicare, or Medicaid), the formulary tier, and whether there are generic alternatives, according to Zishan Khan, MD, a psychiatrist at Mindpath Health.
Formularies
Generic drugs and preferred brands typically receive the best coverage, while non-preferred brands are usually not covered or may require extra information from the healthcare provider. In cases where the BCBS formulary doesn’t include the brand-name version, they may cover generic lisdexamfetamine instead. For example, BCBS of North Dakota made brand-name Vyvanse non-formulary effective January 1, 2026, and listed generic lisdexamfetamine as its preferred option.
Note: Since Vyvanse is a stimulant and a controlled substance (like Adderall), some plans may also have quantity limits, which are restrictions on the amount you can get per month.
Prior authorization
For brand-name drugs, particularly non-preferred ones, insurance plans might require proof that the drugs are medically necessary before covering them. This process is called prior authorization (or preauthorization). It typically necessitates “documentation of a formal ADHD diagnosis, often including standardized rating scales or clinical notes from the provider,” Dr. Khan says. It might also require step therapy, which is “a history of treatment trials with other stimulants and an explanation as to why they were ineffective or poorly tolerated.”
Another typical prior authorization requirement is an explanation of the drug’s medical necessity. Dr. Khan says his reasons for medical necessity often include the fact that it only requires one dose per day and has a smoother delivery and a lower abuse potential than other ADHD medications.
“Insurers will require updated clinical notes every six to 12 months to maintain approval,” Dr. Khan says. So check with your formulary and healthcare provider to understand the full extent of your plan’s prior authorization policies.
Reason for taking it
The FDA has approved Vyvanse for ADHD in people 6 years and older and moderate-to-severe binge eating disorder in adults. When a healthcare provider prescribes it for anything else (e.g., depression or narcolepsy), it’s considered an off-label use. These uses are legal when prescribed by a healthcare provider, but they might not be covered by insurance like an FDA-approved use would.
Medicare and Medicaid coverage
Many BCBS companies offer Medicare Part D, Medicare Advantage, and Medicaid plans with varying Vyvanse coverage. BCBS Medicare Part D and Medicaid plans may cover generic Vyvanse, but they may require prior authorization and quantity limits. Since Medicaid coverage criteria vary by state, it’s important to review your specific plan’s formulary or contact your insurance provider directly.
Does BCBS cover generic Vyvanse?
Even if your Blue Cross Blue Shield plan classifies Vyvanse as a non-preferred brand, that doesn’t mean you’re out of luck. Many BCBS plans will cover generics for ADHD treatment, including lisdexamfetamine dimesylate. In August 2023, the FDA approved the first generics for Vyvanse, which have been widely available at U.S. pharmacies since then.
“Switching to a generic can greatly reduce out-of-pocket costs, especially for families with a high deductible or limited pharmacy benefits,” Dr. Khan says. “It’s pharmacologically identical to brand-name Vyvanse. And in most patients, it is equally effective.”
Generics are essentially the same drug as their brand-name references, since the FDA requires them to use the same active ingredient, strength, dosage form, and route of administration. Studies show that generics match brand-name drugs in performance. So if your health plan covers generic lisdexamfetamine but not brand-name Vyvanse, you’ll get a virtually identical drug at a lower cost.
How much does Vyvanse cost?
People who have prescription drug benefits might not need to pay the full price for Vyvanse. But not everyone has health insurance, and not everyone’s plan will cover it.
For people paying completely out of pocket for their prescriptions, a one-month supply of Vyvanse costs about $555 for 30, 30 mg capsules. Over the course of a year, that comes to over $6,600. Prices fluctuate and vary by pharmacy.
The generic version of Vyvanse, lisdexamfetamine dimesylate, costs an average retail price of $439 for 30, 30 mg capsules.
How much does Vyvanse cost with BCBS?
What you’ll pay for Vyvanse with BCBS depends on the details of your prescription drug plan. On some BCBS plans, your out-of-pocket costs might be $0 for generic lisdexamfetamine, but you might have higher copays for brand-name Vyvanse.
It’s hard to say how much, exactly, you’ll end up paying. However, a 2022 employer health benefits survey from KFF showed that the average copay across insurance company plans with three or more tiers is $11 for first-tier drugs, $37 for second-tier drugs, $67 for third-tier drugs, and $116 for fourth-tier drugs.
How to check whether your BCBS plan covers Vyvanse
Since Blue Cross Blue Shield is a network of individual companies, it doesn’t have one overarching website that houses every plan’s formulary. Instead, you’ll need to find your specific formulary on that company’s website. For example, if you have Blue Cross Blue Shield of Michigan, go to its website, click “Individuals,” click “Resources,” and scroll to the drug list search.
Each website is slightly different, and some may require you to log in to your member account before you can see your formulary. But in most cases, you should be able to find them under a tab titled “Resources” or “Prescription Drugs.” You might also have success searching “Blue Cross Blue Shield drug lists” plus the name of your state.
But if you’d rather avoid the website altogether, you can always call the member services phone number printed on the back of your health insurance card. Make sure you have your plan ID and group number ready, since they’ll likely need that info.
What to do if BCBS won’t cover Vyvanse
If your BCBS plan denies coverage or has high copays for Vyvanse, you still have several options:
- Ask your prescriber to submit a prior authorization request or appeal the denial with documentation of your ADHD or binge eating disorder diagnosis, previous medications you’ve tried, and why Vyvanse is the best option.
- Switch to generic lisdexamfetamine, which most BCBS plans cover at a lower cost and works the same as brand-name Vyvanse.
- Talk with your healthcare provider about a covered Vyvanse alternative, such as Adderall XR, Concerta, Focalin XR, or a non-stimulant option like Strattera.
- Look into the Vyvanse manufacturer savings program if you have commercial insurance and qualify.
Dr. Khan recommends asking your prescribing healthcare provider to “submit a thorough prior authorization, which includes your diagnosis, medication history, and rationale for selecting Vyvanse. The less back and forth with denials and appeals, the more likely an approval will be made.”
How to get Vyvanse without insurance
Blue Cross Blue Shield plans can help you save a lot of money on prescription medications, but so can some other resources. In fact, there are plenty of ways to save on Vyvanse if you don’t have insurance coverage.
Using Vyvanse coupons from SingleCare is completely free and accepted at pharmacies across the country. All you have to do is present your coupon or your SingleCare discount card when you pick up your prescription. Instead of paying $555 for 30, 30 mg brand-name Vyvanse tablets, these coupons can knock the price down as low as $63 for the generic medication. However, you can’t use these savings on top of insurance coverage, so you’ll have to see which discount is better.
The SingleCare prices in this article are the most accurate at the time of publishing in ZIP code 23666 as of May. 7, 2026. Prices vary by pharmacy. Visit our coupon page for updated drug prices at pharmacies near you.
- Attention-deficit/hyperactivity disorder diagnosis, treatment, and Telehealth use in adults, U.S. Centers for Disease Control and Prevention (2024)
- Local Blue Cross and Blue Shield companies and licensees, Blue Cross Blue Shield Association (2026)
- Vyvanse highlights of prescribing information, Food and Drug Administration (2025)
- Pharmacy updates: Vyvanse brand-name formulary removal, Blue Cross Blue Shield of North Dakota (2025)
- First generic drug approvals 2023, Food and Drug Administration (2023)
- Comparative effectiveness of generic and brand-name medication use: A database study of U.S. health insurance claims, PLoS Medicine (2019)
- 2022 Employer Health Benefits Survey, KFF (2022)
- Medically accurate: SingleCare’s Medical Review Board analyzes all of our content to confirm it’s in line with current medical advice.
- Evidence-based: Our content is sourced from reputable U.S.-based healthcare professionals and peer-reviewed research.
- Trustworthy: All of SingleCare’s content goes through a multi-phase review process by our writers, editors, and Medical Board in order to provide clear and credible information.